Paper Details

  1. Home
  2. Paper Details

[Therapeutic consequences of glaucoma treatment with different beta blockers in patients with obstructive respiratory tract diseases].

Author: BleckmannH, DorowP

English AbstractA summary of a research paper/publication written in English for a wider audience.
Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Comparative StudyResearch that compares multiple groups/interventions to determine differences/similarities in outcomes/characteristics.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.

Overview

In patients with chronic obstructive bronchial disease and chronic glaucoma, non-cardioselective beta-blocking agents with intrinsic sympathicomimetic action (ISA) were associated with significant differences in ventilation parameters compared to those without ISA. However, both types effectively lowered intraocular pressure. Choosing beta-blockers with ISA should prioritize minimizing systemic side effects.
Paper Details　
Original Abstract of the Article :
In patients in whom chronic obstructive bronchial disease and chronic glaucoma had been diagnosed, the most important ventilation parameters and intraocular pressures were investigated in a double-blind cross-over study. The airway resistance, the forced expiratory volume within the first second, th...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1055/s-2008-1050717

データ提供：米国国立医学図書館（NLM）

Beta Blockers for Glaucoma: Finding the Right Path in the Desert of Treatment Options

Glaucoma, a leading cause of irreversible blindness, presents a unique challenge for those who suffer from it. This study investigates the effects of beta-blocker eye drops, a common treatment for glaucoma, on patients who also have obstructive respiratory tract diseases. The research explores the impact of these medications on both eye pressure and respiratory function, navigating the intricate desert of co-existing conditions.

Navigating the Desert: Considerations for Selecting Beta Blockers

The study found that certain beta-blockers, specifically those with intrinsic sympathomimetic action (ISA), can negatively impact respiratory function in patients with obstructive respiratory tract diseases. However, the study also found that both types of beta-blockers were equally effective in reducing intraocular pressure. This indicates that while beta-blockers can be a valuable tool for glaucoma treatment, careful consideration must be given to the patient's overall health status and the potential for side effects. It's like choosing the right path through a desert – the most scenic route may not always be the safest or most efficient.

A Wise Choice: Balancing Eye Health and Respiratory Function

When choosing a beta-blocker for glaucoma treatment, it's essential to consider the individual patient's needs and potential risks. For those with obstructive respiratory tract diseases, beta-blockers without ISA may be a safer option. This study emphasizes the importance of a tailored approach to treatment, considering the unique characteristics of each desert landscape, or in this case, each patient's individual needs.

Dr. Camel's Conclusion

This research sheds light on the importance of considering respiratory function when selecting beta-blockers for glaucoma treatment. While beta-blockers can be effective in reducing eye pressure, it's essential to navigate the desert of treatment options wisely, choosing the path that best suits the patient's overall health. Remember, the journey through the desert of glaucoma treatment requires careful consideration and a personalized approach, ensuring that the chosen path leads to both eye health and optimal respiratory function.
Date :
  1. Date Completed 1986-11-04
  2. Date Revised 2013-11-21
Further Info :

Pubmed ID

2876127

DOI: Digital Object Identifier

10.1055/s-2008-1050717

Related Literature

Article Analysis
・Side Effects of metipranolol ophthalmic
SNS
PICO Info
in preparation
Languages

German

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.